Skip to main content
. 2023 Jun 26;4:72. doi: 10.1186/s43058-023-00456-w

Table 2.

Aim 2 evaluation

Measures description Instrument/data source Timing
Primary outcome Carbon monoxide-confirmed abstinence Follow-up patient visit 6 months
Other cessation outcomes Continuous abstinence, quit attempts, smoking reduction Phone assessment 1, 3, 6 months
Patient-level mediators Risk perceptions, self-efficacy, social norms Phone assessment 0, 1, 3, 6 months
Provider-level mediator Provider behavior, delivery of AAA, AAC Patient survey Index visit
Patient-level moderators Age, sex, education, cigarettes/waterpipes per day, nicotine dependence, prior quit attempts Patient survey Index visit
Clinic- and provider-level moderators Clinic characteristics (priority, climate), provider knowledge, attitudes, self-efficacy Provider interview/survey Pre-trial
Cost Intervention delivery costs Cost survey/electronic log Trial

AAA Ask, Advise, Assist, AAC Ask, Advise, Connect